Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
MREO holding history
Mereo BioPharma Group plc in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MREO overviewAll 13F holders of MREOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,585,214−100.0% | Sold out | Holders |
| Q4 2025 | 1,585,214 | $660.6K | 0.2% | +639,299+67.6% | Added | Holders |
| Q3 2025 | 945,915 | $1.95M | 0.7% | +550,915+139.5% | Added | Holders |
| Q2 2025 | 395,000 | $1.07M | 0.4% | −21,468−5.2% | Reduced | Holders |
| Q1 2025 | 416,468 | $937.1K | 0.5% | +35,000+9.2% | Added | Holders |
| Q4 2024 | 381,468 | $1.34M | 0.6% | −3,067−0.8% | Reduced | Holders |
| Q3 2024 | 384,535 | $1.58M | 0.7% | +36,407+10.5% | Added | Holders |
| Q2 2024 | 348,128 | $1.25M | 0.6% | −56,872−14.0% | Reduced | Holders |
| Q1 2024 | 405,000 | $1.34M | 0.6% | −271,494−40.1% | Reduced | Holders |
| Q4 2023 | 676,494 | $1.56M | 0.6% | +80,765+13.6% | Added | Holders |
| Q3 2023 | 595,729 | $768.5K | 0.4% | −110,000−15.6% | Reduced | Holders |
| Q2 2023 | 705,729 | $931.6K | 0.5% | −610,516−46.4% | Reduced | Holders |
| Q1 2023 | 1,316,245 | $930.5K | 0.4% | −733,416−35.8% | Reduced | Holders |
| Q4 2022 | 2,049,661 | $1.54M | 0.5% | +1,863,005+998.1% | Added | Holders |
| Q3 2022 | 186,656 | $161.0K | 0.1% | +186,656 | New | Holders |